Maternale Thrombozytopenie und Thrombozytopathie: Was gilt es in der Schwangerschaft zu beachten?

Translated title of the contribution: Maternal thrombocytopaenia and thrombocytopathy: What should be monitored during pregnancy?

D. W. Lüdders*, D. Manner, R. Reibke, J. Weichert, K. Baumann, F. Hoellen, M. K. Bohlmann

*Corresponding author for this work
1 Citation (Scopus)

Abstract

Sufficient concentration and function of thrombocytes constitute an important part of adequate haemostasis in both pregnant and non-pregnant individuals. Any form of thrombocytopaenia may occur in up to 15% of pregnancies with its most frequent form-gestational thrombocytopaenia-being of rather minor importance due to its mild clinical course. Complex variants of thrombocytopaenia as well as rarely encountered genuine thrombocytopathic diseases, however, require risk-adjusted monitoring both during pregnancy and delivery and constitute a prime example of an interdisciplinary approach for (high) risk patients.

Translated title of the contributionMaternal thrombocytopaenia and thrombocytopathy: What should be monitored during pregnancy?
Original languageGerman
JournalGynakologe
Volume44
Issue number7
Pages (from-to)527-532
Number of pages6
ISSN0017-5994
DOIs
Publication statusPublished - 01.07.2011

Fingerprint

Dive into the research topics of 'Maternal thrombocytopaenia and thrombocytopathy: What should be monitored during pregnancy?'. Together they form a unique fingerprint.

Cite this